ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ARGENX SE
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026
$825.61+6.47 (+0.79%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 42.2
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2015 to 2025
Gross margin
–
Operating margin
–
Net margin
–
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Net income | +55.1% | – | – | – | |
| EPS, diluted | +53.1% | – | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on assets | – | -31.3% | 17.4% | |
| Current ratio | – | 6.26 | 5.23 | |
| Interest coverage | – | -60.0× | 258.2× | |
| Inventory turnover | – | – | – | |
| Capex to revenue | – | 2.6% | – | |
| Diluted shares | 19M | 45M | 66M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Argenx generated $2.66B from operations and spent $13.24M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$2.66B
Used
$13.24M
Capital expenditure$13.24M100%Dividends$00%Share buybacks$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 6 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$1.29B
- Cash generatingOperating cash flow above zero$685.19M
- Return on assets improvedROA up on the prior year18.3% → 20.8%
- Earnings backed by cashOperating cash flow above net income$685.19M vs $1.29B
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose7.29 → 5.23
- No dilutionShare count did not rise65M → 66M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose– → –